| |
Fushih Pan, Ph.D., M.D.
Fushih Pan M.D., Ph.D. is not only the only practicing American Boarded Plastic Surgeon but also a well-known pioneer in regenerative medicine in Asia. His surgical practice is focused on facial rejuvenation. Apart from performing thousands of facelift surgery and aesthetic facial procedures, he also began to isolate ADSC (i.e. Adipose-Derived Stem Cells) from the fat of liposuction and re-injected them to rejuvenate facial skin and hair follicles since 2001. In 2003, Dr. Pan established Lotusbio Technology Ltd. to translate his ADSC technologies into the skin and hair care industry. The anti-aging facial serum allowed him to win First Place in Global Launchpad: Beijing in 2012. In order to accelerate the transdermal delivery of the molecules in the serum, Dr. Pan invented a 3D printed facial wearable device in 2014 which was awarded for two US Patents.
Since 2015, Dr. Pan became interested in translating the heterochronic parabiosis experimental technologies into clinical practice for the treatment of aging-related diseases and conditions. He set up a transfusion center in Cambodia to study the unique components in the young plasma. Based on this, he was able to create a chemical-defined formulation to simulate the beneficial effects of young plasma. In order to simulate the actual effect of in vivo heterochronic parabiosis, Dr. Pan also developed a mathematical model for heterochronic parabiosis which allows him to calculate and optimize optimal dosage and intervals of intermittent plasma exchange for the individual patient.
Dr. Pan received his Ph.D. in Chemistry in 1986 and MD in 1989 both from the University of Chicago. After completed his training in Plastic and Reconstructive Surgery at the University of Chicago Medical Center, he became the Craniofacial Fellow in the Children’s Hospital of Philadelphia and Lecturer in the Department of Surgery at the University of Pennsylvania. |
